INS and Hypoglycemia: It has now been demonstrated that treatment with Sulfonylureas provide a better metabolic equilibrium than insulin by normalizing the HbA1c while strongly reducing the incidence of hypoglycemia in cases of neonatal diabetes with ABCC8 or KCNJ11 mutations.